Revaccination with pneumococcal conjugate vaccine five years after primary immunization improves immunity in patients with chronic lymphocytic leukemiaShow others and affiliations
2025 (English)In: Haematologica, ISSN 0390-6078, E-ISSN 1592-8721, Vol. 110, no 8, p. 1774-1785
Article in journal (Refereed) Published
Abstract [en]
Patients with chronic lymphocytic leukemia (CLL) have an impaired response to vaccination, which calls for improved vaccination strategies. This study aimed to evaluate antibody persistence 5 years after pneumococcal vaccination and response to revaccination. Seventy-four CLL patients and 31 controls, all primary immunized with 13-valent conjugated pneumococcal vaccine (PCV13) or 23-valent polysaccharide vaccine (PPSV23), were included. Antibody persistence was assessed, followed by revaccination with PCV13 and a second revaccination with PCV13 or PPSV23. Serological protection, defined as a serum serotype-specific IgG concentration ≥ 0.35 μg/mL for ≥ 70% of shared serotypes, did not differ significantly in CLL patients primary immunized with PCV13 or PPSV23 (relative risk ratio [RR]=2.7, 95% confidence interval [95% CI]: 0.5-13.1), but was lower in patients than in controls (10% vs. 32%; RR=0.3; 95% CI: 0.1-0.7). Following revaccination with PCV13, serological response, defined as a ≥ 2-fold increase for ≥ 70% of shared serotypes, was 24% in patients primary immunized with PCV13 compared to 12% in those primary immunized with PPSV23 (RR=2.0; 95% CI: 0.6-6.9). A second revaccination with PCV13 significantly improved serological response while PPSV23 did not further improve immunity. Our findings suggest that repeated doses of a T-cell-dependent pneumococcal vaccine improve protection in CLL patients. The study is registered at www.clinicaltrials.gov (NCT05316831).
Place, publisher, year, edition, pages
Ferrata Storti Foundation, 2025. Vol. 110, no 8, p. 1774-1785
National Category
Immunology in the Medical Area Cancer and Oncology
Identifiers
URN: urn:nbn:se:uu:diva-565822DOI: 10.3324/haematol.2024.286942ISI: 001547246400013PubMedID: 40045895OAI: oai:DiVA.org:uu-565822DiVA, id: diva2:1992720
Funder
Nyckelfonden, OLL-890171Nyckelfonden, OLL-974753Region Örebro County, OLL-840421Region Örebro County, OLL-886921Region Örebro County, OLL-929805Region Örebro County, OLL-9169712025-08-282025-08-282025-08-28Bibliographically approved